Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals, Inc. (AGIO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Agios Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1439222.
Total stock buying since 2015: $225,626,257.
Total stock sales since 2015: $157,286,004.
Total stock option exercises since 2015: $24,780,238.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 90,509 | $3,121,937 | 214,923 | $326,913 |
| 2024 | 0 | $0 | 275,285 | $9,802,098 | 387,362 | $4,872,997 |
| 2023 | 0 | $0 | 194,302 | $5,025,995 | 310,521 | $1,505,335 |
| 2022 | 0 | $0 | 845 | $26,168 | 119,506 | $0 |
| 2021 | 0 | $0 | 106,656 | $6,265,395 | 156,788 | $4,142,759 |
| 2020 | 0 | $0 | 64,436 | $3,229,621 | 143,981 | $1,943,537 |
| 2019 | 451,611 | $13,999,941 | 47,950 | $3,126,690 | 121,498 | $1,467,533 |
| 2018 | 851,354 | $57,044,006 | 432,950 | $35,552,561 | 515,767 | $5,601,645 |
| 2017 | 3,122,875 | $154,582,310 | 681,522 | $38,011,569 | 269,401 | $598,898 |
| 2016 | 0 | $0 | 97,536 | $5,752,222 | 194,199 | $1,852,082 |
| 2015 | 0 | $0 | 492,204 | $47,371,748 | 323,656 | $2,468,539 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 11,285 | $414,486 | 27,495 | $3,618 |
| 2025-07 | 0 | $0 | 17,405 | $652,631 | 21,688 | $323,295 |
| 2025-06 | 0 | $0 | 28,958 | $971,249 | 83,191 | $0 |
| 2025-04 | 0 | $0 | 7,497 | $194,172 | 15,933 | $0 |
| 2025-03 | 0 | $0 | 20,288 | $721,033 | 51,244 | $0 |
| 2025-02 | 0 | $0 | 2,272 | $78,134 | 6,896 | $0 |
| 2025-01 | 0 | $0 | 2,804 | $90,232 | 8,476 | $0 |
| 2024-12 | 0 | $0 | 200 | $9,256 | 200 | $3,618 |
| 2024-11 | 0 | $0 | 41,752 | $2,259,244 | 20,000 | $519,798 |
| 2024-09 | 0 | $0 | 2,542 | $124,634 | 7,473 | $0 |
| 2024-08 | 0 | $0 | 11,091 | $474,140 | 27,295 | $0 |
| 2024-06 | 0 | $0 | 13,477 | $652,155 | 51,219 | $0 |
| 2024-04 | 0 | $0 | 7,791 | $214,642 | 15,934 | $0 |
| 2024-03 | 0 | $0 | 7,913 | $252,266 | 0 | $0 |
| 2024-02 | 0 | $0 | 138,931 | $4,665,824 | 142,243 | $4,349,581 |
| 2024-01 | 0 | $0 | 51,588 | $1,149,937 | 122,998 | $0 |
| 2023-09 | 0 | $0 | 2,179 | $54,017 | 7,472 | $0 |
| 2023-08 | 0 | $0 | 45,723 | $1,182,743 | 56,445 | $452,250 |
| 2023-06 | 0 | $0 | 28,796 | $816,651 | 91,657 | $0 |
| 2023-04 | 0 | $0 | 16,363 | $373,894 | 32,296 | $148,085 |
| 2023-03 | 0 | $0 | 40,504 | $907,142 | 48,443 | $362,000 |
| 2023-02 | 0 | $0 | 40,737 | $1,100,548 | 54,208 | $362,000 |
| 2023-01 | 0 | $0 | 20,000 | $591,000 | 20,000 | $181,000 |
| 2022-12 | 0 | $0 | 0 | $0 | 18,125 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-27 | Scadden David (Director) | Sale | 200 | 40.00 | 8,000 |
| 2025-08-27 | Scadden David (Director) | Option Ex | 200 | 18.09 | 3,618 |
| 2025-08-11 | Ballal Rahul D. (Director) | Option Ex | 2,302 | .00 | 0 |
| 2025-08-11 | Smith Cynthia (Director) | Option Ex | 2,302 | .00 | 0 |
| 2025-08-08 | Goff Brian (Chief Executive Officer) | Sale | 11,085 | 36.67 | 406,486 |
| 2025-08-08 | Goff Brian (Chief Executive Officer) | Option Ex | 22,691 | .00 | 0 |
| 2025-07-10 | Scadden David (Director) | Sale | 1,400 | 40.00 | 56,000 |
| 2025-07-10 | Scadden David (Director) | Option Ex | 1,400 | 18.09 | 25,326 |
| 2025-07-09 | Gheuens Sarah (Chief Medical Officer) | Sale | 11,914 | 38.34 | 456,842 |
| 2025-07-09 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 11,914 | 25.01 | 297,969 |
| 2025-07-01 | Gheuens Sarah (Chief Medical Officer) | Sale | 4,091 | 34.17 | 139,789 |
| 2025-07-01 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 8,374 | .00 | 0 |
| 2025-06-24 | Milanova Tsveta (Chief Commercial Officer) | Sale | 2,770 | 33.54 | 92,905 |
| 2025-06-24 | Milanova Tsveta (Chief Commercial Officer) | Option Ex | 6,000 | .00 | 0 |
| 2025-06-24 | Burns James William (Chief Legal Officer) | Sale | 2,799 | 33.54 | 93,878 |
| 2025-06-24 | Burns James William (Chief Legal Officer) | Option Ex | 6,000 | .00 | 0 |
| 2025-06-24 | Gheuens Sarah (Chief Medical Officer) | Sale | 2,909 | 33.54 | 97,567 |
| 2025-06-24 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 6,000 | .00 | 0 |
| 2025-06-24 | Jones Cecilia (Chief Financial Officer) | Sale | 1,780 | 33.54 | 59,701 |
| 2025-06-24 | Jones Cecilia (Chief Financial Officer) | Option Ex | 6,000 | .00 | 0 |
| 2025-06-24 | Goff Brian (Chief Executive Officer) | Sale | 18,700 | 33.54 | 627,198 |
| 2025-06-24 | Goff Brian (Chief Executive Officer) | Option Ex | 38,277 | .00 | 0 |
| 2025-06-20 | Owen Adams Catherine (Director) | Option Ex | 2,120 | .00 | 0 |
| 2025-06-20 | Ballal Rahul D. (Director) | Option Ex | 2,120 | .00 | 0 |
| 2025-06-20 | Scadden David (Director) | Option Ex | 2,120 | .00 | 0 |
| 2025-06-20 | Ho Maykin (Director) | Option Ex | 2,120 | .00 | 0 |
| 2025-06-20 | Smith Cynthia (Director) | Option Ex | 2,120 | .00 | 0 |
| 2025-06-20 | Fouse Jacqualyn A | Option Ex | 2,120 | .00 | 0 |
| 2025-06-20 | Foster-cheek Kaye I (Director) | Option Ex | 2,120 | .00 | 0 |
| 2025-06-20 | Capello Jeffrey D (Director) | Option Ex | 2,120 | .00 | 0 |
| 2025-06-13 | Owen Adams Catherine (Director) | Option Ex | 1,977 | .00 | 0 |
| 2025-06-13 | Capello Jeffrey D (Director) | Option Ex | 1,977 | .00 | 0 |
| 2025-04-10 | Fouse Jacqualyn A | Sale | 7,497 | 25.90 | 194,172 |
| 2025-04-08 | Fouse Jacqualyn A | Option Ex | 15,933 | .00 | 0 |
| 2025-03-03 | Milanova Tsveta (Chief Commercial Officer) | Sale | 1,681 | 35.54 | 59,742 |
| 2025-03-03 | Gheuens Sarah (Chief Medical Officer) | Sale | 4,005 | 35.54 | 142,337 |
| 2025-03-03 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 1,655 | 35.54 | 58,818 |
| 2025-03-03 | Goff Brian (Chief Executive Officer) | Sale | 12,947 | 35.54 | 460,136 |
| 2025-03-01 | Milanova Tsveta (Chief Commercial Officer) | Option Ex | 5,667 | .00 | 0 |
| 2025-03-01 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 13,500 | .00 | 0 |
| 2025-03-01 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 5,577 | .00 | 0 |
| 2025-03-01 | Goff Brian (Chief Executive Officer) | Option Ex | 26,500 | .00 | 0 |
| 2025-02-05 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 2,272 | 34.39 | 78,134 |
| 2025-02-01 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 6,896 | .00 | 0 |
| 2025-01-06 | Milanova Tsveta (Chief Commercial Officer) | Sale | 2,804 | 32.18 | 90,232 |
| 2025-01-03 | Milanova Tsveta (Chief Commercial Officer) | Option Ex | 8,476 | .00 | 0 |
| 2024-12-11 | Scadden David (Director) | Sale | 200 | 46.28 | 9,256 |
| 2024-12-11 | Scadden David (Director) | Option Ex | 200 | 18.09 | 3,618 |
| 2024-11-08 | Ballal Rahul D. (Director) | Sale | 10,000 | 58.34 | 583,400 |
| 2024-11-08 | Ballal Rahul D. (Director) | Option Ex | 10,000 | 25.99 | 259,899 |
| 2024-11-07 | Burns James William (Chief Legal Officer) | Sale | 21,752 | 52.28 | 1,137,194 |
| 2024-11-07 | Ballal Rahul D. (Director) | Sale | 10,000 | 53.87 | 538,650 |
| 2024-11-07 | Ballal Rahul D. (Director) | Option Ex | 10,000 | 25.99 | 259,899 |
| 2024-09-26 | Jones Cecilia (Chief Financial Officer) | Sale | 2,542 | 49.03 | 124,634 |
| 2024-09-26 | Jones Cecilia (Chief Financial Officer) | Option Ex | 7,473 | .00 | 0 |
| 2024-08-11 | Ballal Rahul D. (Director) | Option Ex | 2,302 | .00 | 0 |
| 2024-08-11 | Smith Cynthia (Director) | Option Ex | 2,302 | .00 | 0 |
| 2024-08-08 | Goff Brian (Chief Executive Officer) | Sale | 11,091 | 42.75 | 474,140 |
| 2024-08-08 | Goff Brian (Chief Executive Officer) | Option Ex | 22,691 | .00 | 0 |
| 2024-06-13 | Owen Catherine E. (Director) | Option Ex | 1,976 | .00 | 0 |
| 2024-06-13 | Ballal Rahul D. (Director) | Option Ex | 3,388 | .00 | 0 |
| 2024-06-13 | Scadden David (Director) | Option Ex | 3,388 | .00 | 0 |
| 2024-06-13 | Ho Maykin (Director) | Option Ex | 3,388 | .00 | 0 |
| 2024-06-13 | Smith Cynthia (Director) | Option Ex | 3,388 | .00 | 0 |
| 2024-06-13 | Schenkein David P | Option Ex | 3,388 | .00 | 0 |
| 2024-06-13 | Fouse Jacqualyn A | Option Ex | 3,388 | .00 | 0 |
| 2024-06-13 | Foster-cheek Kaye I (Director) | Option Ex | 3,388 | .00 | 0 |
| 2024-06-05 | Goff Brian (Chief Executive Officer) | Sale | 12,115 | 48.84 | 591,696 |
| 2024-06-05 | Goff Brian (Chief Executive Officer) | Option Ex | 25,527 | .00 | 0 |
| 2024-06-03 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 1,362 | 44.39 | 60,459 |
| 2024-04-10 | Fouse Jacqualyn A | Sale | 7,791 | 27.55 | 214,642 |
| 2024-04-08 | Fouse Jacqualyn A | Option Ex | 15,934 | .00 | 0 |
| 2024-03-07 | Foster-cheek Kaye I (Director) | Sale | 1,285 | 31.62 | 40,631 |
| 2024-03-06 | Foster-cheek Kaye I (Director) | Sale | 4,415 | 31.99 | 141,235 |
| 2024-03-05 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 1,913 | 31.75 | 60,737 |
| 2024-03-05 | Foster-cheek Kaye I (Director) | Sale | 300 | 32.21 | 9,663 |
| 2024-02-27 | Schenkein David P | Sale | 69,329 | 34.24 | 2,374,171 |
| 2024-02-27 | Schenkein David P | Option Ex | 69,329 | 31.64 | 2,193,569 |
| 2024-02-26 | Schenkein David P | Sale | 20,411 | 33.19 | 677,441 |
| 2024-02-26 | Schenkein David P | Option Ex | 20,411 | 31.64 | 645,804 |
| 2024-02-23 | Schenkein David P | Sale | 47,731 | 33.05 | 1,577,509 |
| 2024-02-23 | Schenkein David P | Option Ex | 47,731 | 31.64 | 1,510,208 |
| 2024-02-14 | Burns James William (Chief Legal Officer) | Sale | 545 | 25.14 | 13,701 |
| 2024-02-14 | Gheuens Sarah (Chief Medical Officer) | Sale | 642 | 25.14 | 16,139 |
| 2024-02-14 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 273 | 25.14 | 6,863 |
| 2024-02-12 | Burns James William (Chief Legal Officer) | Option Ex | 1,833 | .00 | 0 |
| 2024-02-12 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 2,162 | .00 | 0 |
| 2024-02-12 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 777 | .00 | 0 |
| 2024-01-24 | Milanova Tsveta (Chief Commercial Officer) | Sale | 1,618 | 21.64 | 35,013 |
| 2024-01-24 | Burns James William (Chief Legal Officer) | Sale | 1,708 | 21.64 | 36,961 |
| 2024-01-24 | Gheuens Sarah (Chief Medical Officer) | Sale | 1,708 | 21.64 | 36,961 |
| 2024-01-24 | Jones Cecilia (Chief Financial Officer) | Sale | 1,886 | 21.64 | 40,813 |
| 2024-01-24 | Goff Brian (Chief Executive Officer) | Sale | 7,635 | 21.64 | 165,221 |
| 2024-01-24 | Fouse Jacqualyn A | Sale | 10,722 | 21.64 | 232,024 |
| 2024-01-20 | Milanova Tsveta (Chief Commercial Officer) | Option Ex | 5,448 | .00 | 0 |
| 2024-01-20 | Burns James William (Chief Legal Officer) | Option Ex | 5,750 | .00 | 0 |
| 2024-01-20 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 5,750 | .00 | 0 |
| 2024-01-20 | Jones Cecilia (Chief Financial Officer) | Option Ex | 5,380 | .00 | 0 |
| 2024-01-20 | Goff Brian (Chief Executive Officer) | Option Ex | 17,018 | .00 | 0 |
| 2024-01-20 | Fouse Jacqualyn A | Option Ex | 23,900 | .00 | 0 |
| 2024-01-09 | Burns James William (Chief Legal Officer) | Sale | 1,163 | 22.99 | 26,737 |
| 2024-01-09 | Gheuens Sarah (Chief Medical Officer) | Sale | 1,789 | 22.99 | 41,129 |
| 2024-01-09 | Goff Brian (Chief Executive Officer) | Sale | 12,066 | 22.99 | 277,397 |
| 2024-01-09 | Fouse Jacqualyn A | Sale | 8,391 | 22.99 | 192,909 |
| 2024-01-05 | Milanova Tsveta (Chief Commercial Officer) | Sale | 2,902 | 22.32 | 64,772 |
| 2024-01-05 | Burns James William (Chief Legal Officer) | Option Ex | 3,250 | .00 | 0 |
| 2024-01-05 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 5,000 | .00 | 0 |
| 2024-01-05 | Goff Brian (Chief Executive Officer) | Option Ex | 25,527 | .00 | 0 |
| 2024-01-05 | Fouse Jacqualyn A | Option Ex | 17,500 | .00 | 0 |
| 2024-01-03 | Milanova Tsveta (Chief Commercial Officer) | Option Ex | 8,475 | .00 | 0 |
| 2023-09-28 | Jones Cecilia (Chief Financial Officer) | Sale | 2,179 | 24.79 | 54,017 |
| 2023-09-26 | Jones Cecilia (Chief Financial Officer) | Option Ex | 7,472 | .00 | 0 |
| 2023-08-17 | Burns James William (Chief Legal Officer) | Sale | 6,395 | 26.28 | 168,060 |
| 2023-08-11 | Ballal Rahul D. (Director) | Option Ex | 2,302 | .00 | 0 |
| 2023-08-11 | Smith Cynthia (Director) | Option Ex | 2,302 | .00 | 0 |
| 2023-08-09 | Foster-cheek Kaye I (Director) | Sale | 25,000 | 25.96 | 648,900 |
| 2023-08-09 | Foster-cheek Kaye I (Director) | Option Ex | 25,000 | 18.09 | 452,250 |
| 2023-08-08 | Goff Brian (Chief Executive Officer) | Sale | 10,178 | 25.48 | 259,335 |
| 2023-08-08 | Goff Brian (Chief Executive Officer) | Option Ex | 22,691 | .00 | 0 |
| 2023-08-07 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 2,918 | 25.39 | 74,096 |
| 2023-08-01 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 1,232 | 26.26 | 32,352 |
| 2023-08-01 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 4,150 | .00 | 0 |
| 2023-06-30 | Milanova Tsveta (Chief Commercial Officer) | Sale | 1,618 | 28.36 | 45,886 |
| 2023-06-30 | Burns James William (Chief Legal Officer) | Sale | 1,707 | 28.36 | 48,410 |
| 2023-06-30 | Gheuens Sarah (Chief Medical Officer) | Sale | 1,707 | 28.36 | 48,410 |
| 2023-06-30 | Jones Cecilia (Chief Financial Officer) | Sale | 1,597 | 28.36 | 45,290 |
| 2023-06-30 | Goff Brian (Chief Executive Officer) | Sale | 11,449 | 28.36 | 324,693 |
| 2023-06-30 | Fouse Jacqualyn A | Sale | 10,718 | 28.36 | 303,962 |
| 2023-06-28 | Milanova Tsveta (Chief Commercial Officer) | Option Ex | 5,449 | .00 | 0 |
| 2023-06-28 | Burns James William (Chief Legal Officer) | Option Ex | 5,750 | .00 | 0 |
| 2023-06-28 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 5,750 | .00 | 0 |
| 2023-06-28 | Jones Cecilia (Chief Financial Officer) | Option Ex | 5,380 | .00 | 0 |
| 2023-06-28 | Goff Brian (Chief Executive Officer) | Option Ex | 25,528 | .00 | 0 |
| 2023-06-28 | Fouse Jacqualyn A | Option Ex | 23,900 | .00 | 0 |
| 2023-06-21 | Scadden David (Director) | Option Ex | 4,975 | .00 | 0 |
| 2023-06-21 | Ho Maykin (Director) | Option Ex | 4,975 | .00 | 0 |
| 2023-06-21 | Schenkein David P | Option Ex | 4,975 | .00 | 0 |
| 2023-06-21 | Foster-cheek Kaye I (Director) | Option Ex | 4,975 | .00 | 0 |
| 2023-04-08 | Fouse Jacqualyn A | Option Ex | 15,933 | .00 | 0 |
| 2023-04-03 | Schenkein David P | Sale | 16,363 | 22.85 | 373,894 |
| 2023-04-03 | Schenkein David P | Option Ex | 16,363 | 9.05 | 148,085 |
| 2023-03-27 | Schenkein David P | Sale | 20,000 | 22.15 | 443,000 |
| 2023-03-27 | Schenkein David P | Option Ex | 20,000 | 9.05 | 181,000 |
| 2023-03-13 | Schenkein David P | Sale | 20,000 | 22.59 | 451,900 |
| 2023-03-13 | Schenkein David P | Option Ex | 20,000 | 9.05 | 181,000 |
| 2023-03-03 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 504 | 24.29 | 12,242 |
| 2023-03-01 | Burns James William (Chief Legal Officer) | Option Ex | 3,833 | .00 | 0 |
| 2023-03-01 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 3,833 | .00 | 0 |
| 2023-03-01 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 777 | .00 | 0 |
| 2023-02-27 | Schenkein David P | Sale | 20,000 | 25.37 | 507,400 |
Insider trading activities including stock purchases, stock sales, and option exercises of AGIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Agios Pharmaceuticals, Inc. (symbol AGIO, CIK number 1439222) see the Securities and Exchange Commission (SEC) website.